Predicting knee osteoarthritis progression using neural network with longitudinal MRI radiomics, and biochemical biomarkers: A modeling study.

PLoS Med

Department of Orthopaedics, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University & The Second Affiliated Hospital of Chengdu, Chongqing Medical University, Chengdu, Sichuan, China.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Knee osteoarthritis (KOA) worsens both structurally and symptomatically, yet no model predicts KOA progression using Magnetic Resonance Image (MRI) radiomics and biomarkers. This study aimed to develop and test the longitudinal Load-Bearing Tissue Radiomic plus Biochemical biomarker and Clinical variable Model (LBTRBC-M) to predict KOA progression.

Methods And Findings: Data from the Foundation of the National Institutes of Health Osteoarthritis Biomarkers Consortium were used. We selected 594 participants with Kellgren-Lawrence grades 1-3 and complete biomarker data. The mean age was 61.6 ± 8.9 years, 58.8% were female, and the racial distribution was 79.3% White or White, 18.0% Black or African American, and 2.7% Asian or other non-White. A total of 1,753 knee MRIs were included across the study period, comprising 594 at baseline, 575 at 1-year follow-up, and 584 at 2-year follow-up. Outcomes included (1) both Joint Space Narrowing (JSN) and pain progression (n = 567), (2) only JSN progression (n = 303), (3) only pain progression (n = 295), and (4) non-progression (JSN or pain) (n = 588), corresponding to an approximate ratio of 2:1:1:2. JSN progression was defined as a minimum joint space width (JSW) loss of ≥0.7 mm, and pain progression as a sustained (≥2 time points) increase of ≥9 points on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale (0-100 scale). Using the eXtreme Gradient BOOSTing (XGBOOST) algorithm, the model was developed in the total development cohort (n = 877) and tested in the total test cohort (n = 876). In the total test cohort, the Area Under the receiver operating characteristic Curve (AUC) of LBTRBC-M for predicting JSN and pain progression, JSN progression, pain progression, and non-progression were 0.880 (95% confidence interval (CI) [0.853, 0.903]), 0.913 (95% CI [0.881, 0.937]), 0.886 (95% CI [0.856, 0.910]), and 0.909 (95% CI [0.888, 0.926]), respectively. The overall accuracy of LBTRBC-M was 70.1%. With LBTRBC-M assistance, the prognostic accuracy of resident physicians (n = 7) improved from 44.7%-49.0% to 64.4%-66.5%. The main limitations include the use of a non-routine MRI sequence, the lack of external validation in independent cohorts, and limited incorporation of all knee joint structures in radiomic feature extraction.

Conclusions: In this study, we observed that longitudinal MRI radiomic features of load-bearing knee joint tissues provide potentially informative markers for predicting knee osteoarthritis progression. These findings may help guide future efforts toward early risk stratification and personalized management of KOA.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12370028PMC
http://dx.doi.org/10.1371/journal.pmed.1004665DOI Listing

Publication Analysis

Top Keywords

pain progression
20
knee osteoarthritis
12
jsn pain
12
jsn progression
12
progression
11
predicting knee
8
osteoarthritis progression
8
longitudinal mri
8
mri radiomics
8
joint space
8

Similar Publications

Background: Laboratory animal veterinarians play a crucial role as a bridge between the ethical use of laboratory animals and the advancement of scientific and medical knowledge in biomedical research. They alleviate pain and reduce distress through veterinary care of laboratory animals. Additionally, they enhance animal welfare by creating environments that mimic natural habitats through environmental enrichment and social associations.

View Article and Find Full Text PDF

X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells.

Calcif Tissue Int

September 2025

FirmoLab, Fondazione F.I.R.M.O. Onlus and Stabilimento Chimico Farmaceutico Militare (SCFM), 50141, Florence, Italy.

X-linked hypophosphatemia (XLH) is a rare and progressive disease, due to inactivating mutations in the phosphate-regulating endopeptidase homolog X-linked (PHEX) gene. These pathogenic variants result in elevated circulating levels of fibroblast growth factor 23 (FGF23), responsible for the main clinical manifestations of XLH, such as hypophosphatemia, skeletal deformities, and mineralization defects. However, XLH also involves muscular disorders (muscle weakness, pain, reduced muscle density, peak strength, and power).

View Article and Find Full Text PDF

A qualitative study using in-depth interviews was conducted to identify the level of knowledge, beliefs, and perceptions of family members and healthcare workers regarding the use of morphine as a pain treatment for individuals at the end of life. The study included healthcare professionals and caregivers of individuals who had died from serious illnesses affiliated with a rural health center in an inland city in the western region of Uruguay between August 2021 and June 2022. The findings may contribute to understanding the determinants that influence opioid use in healthcare centers lacking access to specialized palliative care.

View Article and Find Full Text PDF

Targeting USP21 to inhibit abdominal aortic aneurysm progression by suppressing the phenotypic transition of vascular smooth muscle cells.

Cell Rep Med

September 2025

Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan 250012, China; Shandong Provincial Clinical Research Center for Emergency and Critical Care Medicine, Institute of Emergency and Critical Care Medicine of Shandong University, Chest Pain Center, Qilu Hospital of Shandong U

Abdominal aortic aneurysm (AAA) is a life-threatening condition lacking effective treatment. We investigate the role of the deubiquitinating enzyme USP21 in AAA development. Proteomic analysis reveals significant upregulation of USP21 in murine and human abdominal aortic tissues.

View Article and Find Full Text PDF

ObjectiveThis study aimed to evaluate the efficacy and safety of hyperthermic intraperitoneal intraoperative chemotherapy (HIPEC) in patients with advanced ovarian cancer.MethodsA total of 200 patients with advanced ovarian cancer were enrolled in this retrospective study and randomly allocated to two groups (research registry number: 11353). On the first day after abdominal closure, routine treatment was performed in the non-HIPEC group, whereas HIPEC was performed in the HIPEC group.

View Article and Find Full Text PDF